key: cord-1042295-2cruk7tp
authors: Ramanathan, Ramnath Santosh; Wachsman, Ari
title: Coronavirus disease-19 (COVID-19) related acute stroke causing Transient Global Amnesia
date: 2021-03-05
journal: J Stroke Cerebrovasc Dis
DOI: 10.1016/j.jstrokecerebrovasdis.2021.105738
sha: 6201fb6ab228317de51b7faf5efe95a1eecc4c36
doc_id: 1042295
cord_uid: 2cruk7tp

nan

Transient global amnesia (TGA) presents as an acute anterograde amnesia that generally resolves within 24 hrs. (1) Werner et al. had noted increasing TGA since severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outbreak in their hospital in Germany and reported 16 patients with TGA between February 1 st and May 15 th 2020 compared to their 10-year average of 9.7 (2) In our series we noted 2 patients who presented with TGA secondary to acute hippocampal stroke in COVID-19 positive patients.

There is evidence that SARS-CoV-2 causes more thrombotic vascular events like stroke than other coronavirus infections. The reported incidence of stroke in SARS-CoV-2 ranges from 1% to 6% (3).

48-year female with medical history of hypertension admitted with amnesia and confusion, found to be COVID-19 positive on admission. The patient was found on her couch confused and perseverative. Patient's amnestic symptoms improved within 24 hrs. of admission but patient continued to be amnestic to the events around her admission. Vitals were stable except BP at 155/102 mmHg. Patient had normal neurological examination. MRI brain (Figure 1 ) done showed small acute bilateral medial temporal infarcts. EEG did not show any seizure activity. D-dimer was reported normal.

71-year female with medical history of hypertension was admitted with amnesia, found to be COVID-19 positive. COVID-19 testing was done due to recent exposure. Patient was amnestic to the events that occurred leading to her admission, and kept repeating herself. Patient's symptoms resolved in about 8 hours following admission but patient continued to have amnesia to the events around her hospitalization. Vitals were stable on admission except for high BP of 173/100 mmHg on admission. Patient had normal neurological examination. Electroencephalogram (EEG) did not show any seizure activity or epileptiform discharges. MRI brain ( Figure 2 ) showed acute small right medial temporal infarct. MR angiogram head/neck did not show any acute large vessel occlusion. D-dimer was slightly on higher side at 315.

The estimated incidence of TGA is around 5.2 to 10 per 100,000 per year (4). The etiology of TGA is not clear but multiple theories have been postulated which includes a possible vascular etiology, epilepsy, migraine like episode with cortical spreading depression or underlying psychogenic disorder (5). Involvement of mediobasal temporal lobe and/or hippocampus leads to the clinical symptoms of TGA. The hallmark of TGA is prominent anterograde amnesia, characterized by an inability to form new memories. Patients generally perseverate, and repetitively ask the same questions, as well as are disoriented in time. The neurological examination is generally normal and patient needs to be observed till atleast the amnesia resolves. In our 2 cases, patients had TGA symptoms, with tiny stroke in the medial temporal lobe, and were COVID-19 positive. In COVID-19 the mechanism of stroke has been secondary to viral endothelial injury in form of endothelitis and endotheliopathy, hypercoagulable state from systemic inflammation, and cytokine storm. (6). Axonal transport of SARS-CoV-2 to the olfactory bulb via cribriform plate may result in loss of smell experienced with COVID-19 infections. COVID-19 associated coagulopathy could be related to inflammatory cytokine storm. Viral spike glycoprotein binds to angiotensin converting enzyme 2 (ACE2) resulting in ACE2 downregulation, which in turn overactivate classical renin angiotensin system (RAS) and underactivate the alternative RAS signal in the brain, ultimately resulting in cascade of inflammation and coagulopathy leading to stroke in COVID-19 infection (7). Various neurological manifestation has been reported in COVID-19 patients, including stroke, encephalopathy, encephalitis, headache, dizziness, loss of smell and taste, seizures, refractory status epilepticus, acute disseminated encephalomyelitis (ADEM), myelitis, leukoencephalopathy, neuroleptic malignant syndrome, Kawasaki syndrome, Guillain-Barré syndrome, myopathy, as well as critical illness neuromyopathy (8). But there has not been much literature about TGA in COVID-19 patients. Werner et al's report which mentions about possible increase in TGA in their hospital during COVID-19 pandemic but these patients did not show any COVID-19 symptoms. It is likely possible that high stress level in the community during these unprecedented pandemics of COVID-19 might trigger TGA. Hussein et al reported TGA as neurological prodrome to respiratory failure in a COVID-19 patient (9). In that case Hussein et al described a 53-year-old patient who was admitted with TGA symptoms and a week later was admitted to the hospital with acute respiratory and systemic symptoms of COVID-19. No structural damage in MRI brain was reported in that case. And in that case author was not clear if association of TGA prodrome was secondary to stress of developing infection or was just coincidental. Nishizawa et al reported a case of TGA with bilateral hippocampal lesions during the COVID 19 crisis but again in their case patient was not found to be COVID-19 positive and TGA was attributed to the stress of the current ongoing pandemic (10). But in our cases TGA occurred in patients who were positive for COVID-19, had cough for about a week, and developed TGA symptoms along with structural damage suggesting acute strokes in MRI brain. Ours is the first report of 2 patients of TGA in COVID-19 positive patients with stroke. One of our patients had small acute bilateral medial temporal lobe strokes while the other had right medial temporal lobe acute infarct. We hypothesize that COVID-19 resulted in thrombotic vascular events in the medial temporal regions leading to TGA rather than TGA being caused by the stress of the ongoing pandemic as reported in other couple cases. TGA needs to be added to the ever-growing repertoire of varied neurological manifestations of COVID-19

TGA could be the initial manifestation of COVID-19 in certain cases and more reporting is needed to see pathogenesis and characteristic neuroimaging findings in these patients. 

What does transient global amnesia really mean? Review of the literature and thorough study of 142 cases

Increased incidence of transient global amnesia during the Covid-19 crisis?

SARS-CoV-2 and stroke in a New York healthcare system

Transient global amnesia: clinical characteristics and prognosis

Transient global amnesia

Neurological associations of COVID-19

Coronavirus Disease 2019 and Stroke: Clinical Manifestations and Pathophysiological Insights

Central Nervous System Manifestations Associated with COVID-19

Transient Global Amnesia as a Possible First Manifestation of COVID-19

Transient global amnesia with bilateral hippocampal lesions during the COVID-19 global outbreak